Cardiff Oncology, Inc. (CRDF)
NASDAQ: CRDF · Real-Time Price · USD
2.810
-0.070 (-2.43%)
At close: Jan 20, 2026, 4:00 PM EST
2.780
-0.030 (-1.07%)
After-hours: Jan 20, 2026, 7:08 PM EST
Cardiff Oncology Market Cap
Cardiff Oncology has a market cap or net worth of $189.28 million as of January 20, 2026. Its market cap has decreased by -14.70% in one year.
Market Cap
189.28M
Enterprise Value
129.70M
1-Year Change
-14.70%
Ranking
Category
Stock Price
$2.81
Market Cap Chart
Since May 29, 2012, Cardiff Oncology's market cap has increased from $56.00M to $189.28M, an increase of 238.01%. That is a compound annual growth rate of 9.34%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 16, 2026 | 194.00M | 2.48% |
| Dec 31, 2025 | 189.30M | -14.69% |
| Dec 31, 2024 | 221.90M | 235.70% |
| Dec 29, 2023 | 66.10M | 5.76% |
| Dec 30, 2022 | 62.50M | -73.71% |
| Dec 31, 2021 | 237.70M | -62.60% |
| Dec 31, 2020 | 635.50M | 6,519.79% |
| Dec 31, 2019 | 9.60M | -20.66% |
| Dec 31, 2018 | 12.10M | 3.42% |
| Dec 29, 2017 | 11.70M | -81.80% |
| Dec 30, 2016 | 64.30M | -59.94% |
| Dec 31, 2015 | 160.50M | 97.42% |
| Dec 31, 2014 | 81.30M | -25.07% |
| Dec 31, 2013 | 108.50M | 10.38% |
| Dec 31, 2012 | 98.30M | 75.54% |
| May 29, 2012 | 56.00M | - |
View and export this data all the way back to 2012. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tiziana Life Sciences | 197.85M |
| Editas Medicine | 197.19M |
| Humacyte | 196.86M |
| Galectin Therapeutics | 192.77M |
| SAB Biotherapeutics | 190.90M |
| Quince Therapeutics | 190.43M |
| Minerva Neurosciences | 189.11M |
| Cartesian Therapeutics | 188.01M |